Group 1 - The core product, Tirzepatide (Mounjaro), was launched in August at Dingdang Health pharmacies in Beijing, Guangzhou, and Shenzhen, and is developed by Eli Lilly [1] - The Chinese weight management market is projected to reach 21.5 billion yuan by 2025, coinciding with the National Health Commission's three-year "Weight Management Year" initiative starting in 2025 [1] - Dingdang Health has been active in expanding its offerings, including partnerships with Yino Pharmaceutical and Novo Nordisk to provide comprehensive weight management solutions [1] Group 2 - Dingdang Health has established four major intelligent warehouses across North, East, South, and Central China, improving picking efficiency by 80% and reducing labor costs by 30% [1] - The company has implemented a digital upgrade in its smart pharmacies, significantly enhancing operational efficiency, with store revenue increasing over tenfold [1] - Dingdang Health has launched cold chain delivery services in Beijing, Shanghai, and Shenzhen to ensure the quality of temperature-sensitive medications [2]
叮当健康：加码体重管理市场布局，持续推进原研药企合作